GENMAB - Dusseldorf Stock Exchang
GENMAB - Dusseldorf Stock Exchang operates in Diversified Metals & Mining.
GENMAB - Dusseldorf Stock Exchang (GE9) - Total Liabilities
Latest total liabilities as of September 2024: €7.74 Billion EUR
Based on the latest financial reports, GENMAB - Dusseldorf Stock Exchang (GE9) has total liabilities worth €7.74 Billion EUR as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
GENMAB - Dusseldorf Stock Exchang - Total Liabilities Trend (2016–2023)
This chart illustrates how GENMAB - Dusseldorf Stock Exchang's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
GENMAB - Dusseldorf Stock Exchang Competitors by Total Liabilities
The table below lists competitors of GENMAB - Dusseldorf Stock Exchang ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
iSpecimen Inc
NASDAQ:ISPC
|
USA | $5.92 Million |
|
Klimator AB
ST:KLIMAT
|
Sweden | Skr17.80 Million |
|
Sixty Six Capital Inc
OTCQB:HYHDF
|
USA | $4.04 Million |
|
Loop Energy Inc.
PINK:LPENF
|
USA | $16.73 Million |
|
Can B Corp
NASDAQ:CANB
|
USA | $11.64 Million |
Liability Composition Analysis (2016–2023)
This chart breaks down GENMAB - Dusseldorf Stock Exchang's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.17 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.24 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how GENMAB - Dusseldorf Stock Exchang's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for GENMAB - Dusseldorf Stock Exchang (2016–2023)
The table below shows the annual total liabilities of GENMAB - Dusseldorf Stock Exchang from 2016 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | €3.68 Billion | +29.68% |
| 2022-12-31 | €2.84 Billion | +16.70% |
| 2021-12-31 | €2.43 Billion | +20.23% |
| 2020-12-31 | €2.02 Billion | +84.49% |
| 2019-12-31 | €1.10 Billion | +145.39% |
| 2018-12-31 | €446.64 Million | +35.04% |
| 2017-12-31 | €330.75 Million | -19.63% |
| 2016-12-31 | €411.54 Million | -- |